Delivery Order SPE2DB24D2205-SPE2DB25FEFAN
Award Date 7/17/25
Potential Completion Date 8/7/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $34,576.32 and is a firm fixed-price delivery order. It has an ultimate completion date of June 17, 2025. The contract is not set aside and is open to full and open...
- This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGE-ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,440.70 firm fixed price delivery order was competitively awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 7, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $5,042.38, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of May 16, 2025....
- This federal contract award is for the delivery of XOLAIR 150 MG/1.2 ML POWDER VLS pharmaceutical product to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $11,679.50 and a completion date of August 1, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
- This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), a defense agency. The $34,576.32 firm fixed-price delivery order contract has a performance period ending on July 14, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of the pharmaceutical product XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The $1,800.90 firm fixed-price delivery order contract has an ultimate completion date of July 21, 2025 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is not set-aside and represents part of a larger...
- This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGE/ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Medical Supply Chain. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, in the amount of $72,034. The contract is a delivery order with a firm fixed price and an ultimate completion date of August 6, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of XOLAIR 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price of $5,196.57 and a completion date of August 6, 2025. It is not a set-aside contract. The award is part of a larger Indefinite Delivery Contract (IDC)...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed-price pricing type and a ceiling value of $5,762.72. It is for the pharmaceutical product "XOLAIR 150 MG/ML SYRINGE" and has an ultimate completion date of July 7, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds...
- This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,440.70 delivery order contract is for the supply of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product. The contract is a firm fixed price, non-set-aside award with a period of performance through July 1, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00...